CTSS and fucosidosis: Additional inflammatory genes including major histocompability class II, chemokine C-C motif receptor-1 and 5, cathepsin S and IL1A are upregulated in preclinical fucosidosis frontal cortex [21] and may also be suitable candidates for monitoring responses to therapy in the future.